COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04979884


Column Value
Trial registration number NCT04979884
Full text link
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

First author
Last imported at : July 28, 2023, 8 a.m.
Source : ClinicalTrials.gov

None

Contact
Last imported at : July 28, 2023, 8 a.m.
Source : ClinicalTrials.gov

None

Registration date
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

2021-07-28

Recruitment status
Last imported at : July 28, 2023, 8 a.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Open label

Center
Last imported at : July 28, 2023, 8 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : July 28, 2023, 8 a.m.
Source : ClinicalTrials.gov

inclusion criteria: current infection with covid-19 written informed consent confirmed diagnosis of covid-19 by pcr (polymerase chain reaction) tests and/or positive serology or any existing and validated diagnostic covid-19 parameters during this time. 18yrs ≥ age <66 yrs chest x-ray showing suggestive of covid-19 disease. both gender the presence of pulmonary fibrosis or hyper inflammation signs or a syndrome of cytokine release defined as any of the following:: leukopenia or lymphopenia, ferritin > 500ng/ml or d-dimers ≥ 500 ng/ml hs>90

Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

lactation and pregnancy women unlikely to survive beyond 48h need for mechanical ventilation. cases of multiorgan failure or abnormal renal function and shock. malignancies, autoimmune disease, perforation of the bowels or diverticulitis. active bacterial or fungal infection. we define impairment of cardiac function as poorly controlled heart diseases, cardiac insufficiency, unstable angina pectoris, myocardial infarction within 1 year before enrollment, supraventricular or ventricular arrhythmia needs treatment or intervention, uncontrolled hypertension (>180/110 mmhg. levels of serum transaminase >5 upper references rang symptoms of active tuberculosis or human immunodeficiency virus (hiv) positivity the patient receiving vaccines: live, attenuated vaccines subjects received monoclonal antibodies within one week before admission. patients receiving high-dose systemic steroids (> 20 mg methylprednisolone or equivalent), immunosuppressant or immunomodulatory drugs contraindications for use in people with psoriasis include concomitant treatment with methotrexate, other immunosuppressant agents, coal tar, or radiation therapy. -

Number of arms
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

2

Funding
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Alexandria University

Inclusion age min
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

65

Countries
Last imported at : July 28, 2023, 8 a.m.
Source : ClinicalTrials.gov

Egypt

Type of patients
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Moderate/severe disease at enrollment

Severity scale
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : July 28, 2023, 8 a.m.
Source : ClinicalTrials.gov

102

primary outcome
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Percentage of subjects with a 6-point ordinal scale showing each severity level

Notes
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

None

Phase
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Phase 3

Arms
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 283, "treatment_name": "Ciclosporin", "treatment_type": "Immunosuppressants", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]